title: Role of the tumor necrosis factor ligand APRIL in Hodgkin's lymphoma: a retrospective study including 107 cases.
authors.forename: Philip
authors.initials: P
authors.lastname: Went
authors.forename: Alexander
authors.initials: A
authors.lastname: Tzankov
authors.forename: Juerg
authors.initials: J
authors.lastname: Schwaller
authors.forename: Jakob
authors.initials: J
authors.lastname: Passweg
authors.forename: Eddy
authors.initials: E
authors.lastname: Roosnek
authors.forename: Bertrand
authors.initials: B
authors.lastname: Huard
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D015331:Cohort Studies; D005500:Follow-Up Studies; D006689:Hodgkin Disease / Q000175:diagnosis / Q000378:metabolism* / Q000628:therapy; D006801:Humans; D007150:Immunohistochemistry; D009367:Neoplasm Staging; D012008:Recurrence; D012189:Retrospective Studies; D016019:Survival Analysis; D016896:Treatment Outcome; D053300:Tumor Necrosis Factor Ligand Superfamily Member 13 / Q000096:biosynthesis / Q000378:metabolism*
chemical_list: C114631:TNFSF13 protein, human; D053300:Tumor Necrosis Factor Ligand Superfamily Member 13